ATE361319T1 - Herstellungsverfahren von lactalbumin - Google Patents

Herstellungsverfahren von lactalbumin

Info

Publication number: ATE361319T1
Authority: AT; Austria
Prior art keywords: lactalbumin; alpha; oligomeric form; ion exchange; exchange medium
Prior art date: 1997-11-21

Application number

AT98955823T

Other languages

English (en)

Inventor

Catharina Svanborg

Per Anders Hakansson

Malin Wilhelmina Svensson

Original Assignee

Nya Hamlet Pharma Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-21

Filing date

1998-11-23

Publication date

2007-05-15

1997-11-21 Priority claimed from GBGB9724725.8A external-priority patent/GB9724725D0/en

1998-11-23 Application filed by Nya Hamlet Pharma Ab filed Critical Nya Hamlet Pharma Ab

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE361319T1 publication Critical patent/ATE361319T1/de

Links

102000004407 Lactalbumin Human genes 0.000 title abstract 7
108090000942 Lactalbumin Proteins 0.000 title abstract 7
238000004519 manufacturing process Methods 0.000 title abstract 2
235000021241 α-lactalbumin Nutrition 0.000 abstract 6
239000005018 casein Substances 0.000 abstract 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 2
235000021240 caseins Nutrition 0.000 abstract 2
238000005342 ion exchange Methods 0.000 abstract 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
101000946377 Bos taurus Alpha-lactalbumin Proteins 0.000 abstract 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
239000005642 Oleic acid Substances 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
235000020256 human milk Nutrition 0.000 abstract 1
210000004251 human milk Anatomy 0.000 abstract 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
238000002203 pretreatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

AT98955823T 1997-11-21 1998-11-23 Herstellungsverfahren von lactalbumin ATE361319T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9724725.8A GB9724725D0 (en)	1997-11-21	1997-11-21	Protein production process
GBGB9812202.1A GB9812202D0 (en)	1997-11-21	1998-06-05	Protein production process

Publications (1)

Publication Number	Publication Date
ATE361319T1 true ATE361319T1 (de)	2007-05-15

Family

ID=26312643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98955823T ATE361319T1 (de)	1997-11-21	1998-11-23	Herstellungsverfahren von lactalbumin

Country Status (9)

Country	Link
US (2)	US7053185B1 (de)
EP (1)	EP1032596B1 (de)
JP (1)	JP2001524491A (de)
AT (1)	ATE361319T1 (de)
AU (1)	AU1254199A (de)
DE (1)	DE69837719T2 (de)
DK (1)	DK1032596T3 (de)
ES (1)	ES2286860T3 (de)
WO (1)	WO1999026979A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6815419B1 (en) *	1999-07-28	2004-11-09	Morinaga Milk Industry Co., Ltd.	Antiulcer agent
US20030077255A1 (en) *	2001-04-16	2003-04-24	Sabharwal Hemant K.	Compositions of bacteria and alpha-lactalbumin and uses thereof
GB0205347D0 (en) *	2002-03-07	2002-04-24	Svanborg Catharina	Biologically active complex
GB0210464D0 (en)	2002-05-08	2002-06-12	Svanborg Catharina	Therapeutic treatment
US20090192296A1 (en) *	2006-02-01	2009-07-30	National University Corporation Hokkaido University	Method for Producing Denatured Substance of Lactalbumin
WO2008138348A1 (en) *	2007-05-09	2008-11-20	Nya Hamlet Pharma Ab	Preparation of complexed lactalbumin
US8796218B2 (en)	2009-01-09	2014-08-05	Hamlet Pharma Ab	Complex and production process
EP2643010B1 (de)	2010-11-24	2016-11-16	HAMLET Pharma AB	Biologisch aktiver komplex und seine herstellung
CA2878292A1 (en)	2012-07-05	2014-01-09	The Research Foundation For The State University Of New York	Potentiation of antibiotic treatment with a protein-lipid complex
HUE038910T2 (hu) *	2012-08-09	2018-12-28	Hamlet Pharma Ab	Profilaktikus és gyógytáp terápia
CN104399065A (zh) *	2014-10-17	2015-03-11	广东海洋大学	一种可诱导人乳腺癌细胞凋亡的牛乳蛋白脂肪酸修饰物及其制备方法
EP3815763A1 (de) *	2019-11-01	2021-05-05	I3 Membrane GmbH	Verfahren und vorrichtung zur gleichspannungsgesteuerten adsorption und desorption an geladenen membranen
CN120239612A (zh)	2022-10-03	2025-07-01	林南制药公司	一种用于治疗或预防癌症的包含α-乳清蛋白和脂肪酸或脂质的复合物
GB202303177D0 (en)	2023-03-03	2023-04-19	Linnane Pharma Ab	Method of predicting response to treatment
WO2025186107A1 (en)	2024-03-04	2025-09-12	Linnane Pharma Ab	Therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2961625B2 (ja) *	1991-01-21	1999-10-12	雪印乳業株式会社	α−ラクトアルブミン含有量の高い組成物の製造方法
EP0776214B1 (de) *	1994-08-16	1999-07-28	Hemant Sabharwal	Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung

1998
- 1998-11-23 DK DK98955823T patent/DK1032596T3/da active
- 1998-11-23 WO PCT/IB1998/001919 patent/WO1999026979A1/en not_active Ceased
- 1998-11-23 DE DE69837719T patent/DE69837719T2/de not_active Expired - Lifetime
- 1998-11-23 US US09/554,704 patent/US7053185B1/en not_active Expired - Fee Related
- 1998-11-23 EP EP98955823A patent/EP1032596B1/de not_active Expired - Lifetime
- 1998-11-23 JP JP2000522135A patent/JP2001524491A/ja active Pending
- 1998-11-23 AU AU12541/99A patent/AU1254199A/en not_active Abandoned
- 1998-11-23 ES ES98955823T patent/ES2286860T3/es not_active Expired - Lifetime
- 1998-11-23 AT AT98955823T patent/ATE361319T1/de not_active IP Right Cessation
2006
- 2006-01-27 US US11/275,760 patent/US7524932B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2286860T3 (es)	2007-12-01
US20060229436A1 (en)	2006-10-12
AU1254199A (en)	1999-06-15
DE69837719T2 (de)	2008-01-31
WO1999026979A1 (en)	1999-06-03
US7053185B1 (en)	2006-05-30
JP2001524491A (ja)	2001-12-04
DE69837719D1 (de)	2007-06-14
EP1032596A1 (de)	2000-09-06
US7524932B2 (en)	2009-04-28
EP1032596B1 (de)	2007-05-02
DK1032596T3 (da)	2007-09-10

Similar Documents

Publication	Publication Date	Title
DK1032596T3 (da)	2007-09-10	Fremgangsmåde til fremstilling af lactalbumin
IL95480A0 (en)	1991-06-30	Process for the preparation of cyclic amino acids,and intermediates
EP0187048A3 (de)	1988-09-21	Verfahren zur Herstellung von einem Soja-Hydrolysat, enzymatisch modifiziertes Soja-Eiweiss und seine Verwendung als Eiweissersatz
ES8104412A1 (es)	1981-04-16	Procedimiento para la preparacion de un hidrolizado de pro- teinas purificado.
HUP9900920A2 (hu)	1999-07-28	Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
IL117320A0 (en)	1996-06-18	Process for producing a protein
AU7506396A (en)	1997-05-29	Composition for improving pancreatic function
MX173384B (es)	1994-02-24	Procedimiento de produccion de kappa-caseinoglicomacropeptido
ES2159519T3 (es)	2001-10-16	Procedimiento para producir/secretar una proteina por un moho transformado usando regiones de regulacion de la expresion/secrecion derivadas de un gen de endoxilanasa ii de aspergillus.
PT86358A (fr)	1988-01-01	Procede de fabrication d:une hydrolysat enzymatique de proteines riche en di et tri-peptides utilisable notamment en nutrution artificielle et en dietetique
MY103362A (en)	1993-06-30	Production of proteins in active forms
ATE131490T1 (de)	1995-12-15	Verfahren zur herstellung von gereinigten albuminlösungen
ATE128814T1 (de)	1995-10-15	Käseherstellungsverfahren.
HUT45564A (en)	1988-07-28	Process for producing hirudine variants
DE3568048D1 (en)	1989-03-09	Process for the synthesis of peptides
BG98761A (en)	1995-03-31	Substituted pyrroles
HUP0102562A2 (hu)	2001-10-28	Expressziós vektor egyetlen lépésből álló tisztítási eljárásban történő alkalmazásra
BG104801A (en)	2001-04-30	Indole-2,3-dione-3-oxime derivatives for therapeutical use
AU7546687A (en)	1988-01-12	Method for producing a new proteolytic complex stimulating the activity of the pancreas and its applications in zootechny
SE8502315D0 (sv)	1985-05-09	Improved transamination process for producing amino acids
HU902754D0 (en)	1991-12-30	Process for producing germinal biphosphonic acids and derivatives thereof
ATE154608T1 (de)	1997-07-15	Verwendung einer mischung von peptiden and aminosäuren für die prophylaxis oder behandlung von dementia
NZ333412A (en)	2000-10-27	Plant proteins treated to reduce isoflavones, manganese and nucleotides and nutritional products made therefrom
DE50001961D1 (de)	2003-06-05	Verfahren zur herstellung von eiweisshydrolysaten
ES8900224A1 (es)	1989-04-16	Un procedimiento para la preparacion de un hidrolizado proteinico.

Legal Events

Date

Code

Title

Description

2007-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1032596

Country of ref document: EP

2011-08-15

REN

Ceased due to non-payment of the annual fee